This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Neuraminidase
From Proteopedia
(Difference between revisions)
| Line 4: | Line 4: | ||
See also<br /> | See also<br /> | ||
*[[Avian Influenza Neuraminidase, Tamiflu and Relenza]]<br /> | *[[Avian Influenza Neuraminidase, Tamiflu and Relenza]]<br /> | ||
| + | *[[Zanamivir]] (Relenza)<br /> | ||
*[[Molecular Playground/Relenza]]<br /> | *[[Molecular Playground/Relenza]]<br /> | ||
*[[Molecular Playground/Tamiflu]]<br /> | *[[Molecular Playground/Tamiflu]]<br /> | ||
Revision as of 09:20, 29 February 2016
Neuraminidase (NAN) cleaves the glycosidic bonds of neuraminic acid. The viral NAN is a drug target for prevention of influenza.
See also
- Avian Influenza Neuraminidase, Tamiflu and Relenza
- Zanamivir (Relenza)
- Molecular Playground/Relenza
- Molecular Playground/Tamiflu
- Oseltamivir (Tamiflu)
- Treatments:Influenza
- User:Michael Strong/H1N1/NA for Influenza virus neuraminidase
- User:Michael Strong/H1N1/NA/MSA for multiple sequence alignment.
For other inhibitors see
- Neuraminidase Inhibitor Pharmacokinetics
- Carbohydrate binding domain from Streptococcus pneumoniae NanA sialidase complexed with 3'-sialyllactose
- Treatments:Neuraminidase Inhibitor Pharmacokinetics References
.
3D structures of Neuraminidase
Updated on 29-February-2016
Proteopedia Page Contributors and Editors (what is this?)
Michal Harel, Alexander Berchansky, Joel L. Sussman, Eran Hodis
